• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

淋病奈瑟菌临床株和参考株对氯硫酰胺的敏感性。

Susceptibility to Closthioamide among Clinical and Reference Strains of Neisseria gonorrhoeae.

机构信息

Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.

Centre for Synthetic Biology and Innovation, Department of Life Sciences, Imperial College London, London, United Kingdom.

出版信息

Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.00929-17. Print 2017 Oct.

DOI:10.1128/AAC.00929-17
PMID:28784667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5610491/
Abstract

is one of the leading antimicrobial resistance threats worldwide. This study determined the MICs of closthioamide to be 0.008 to 0.5 mg/liter for clinical strains and related species. Cross-resistance with existing antimicrobial resistance was not detected, indicating that closthioamide could be used to treat drug-resistant .

摘要

耐碳青霉烯肠杆菌科（ CRE ）是全球主要的抗微生物药物耐药性威胁之一。本研究确定了临床株和相关种属对氯硫酰胺的 MIC 值为 0.008 至 0.5 毫克/升。与现有抗微生物药物耐药性的交叉耐药性未被检测到，表明氯硫酰胺可用于治疗耐药性 。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/5610491/8baada804824/zac0101765830002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/5610491/bd4b02091dff/zac0101765830001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/5610491/8baada804824/zac0101765830002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/5610491/bd4b02091dff/zac0101765830001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eacf/5610491/8baada804824/zac0101765830002.jpg

相似文献

1
Susceptibility to Closthioamide among Clinical and Reference Strains of Neisseria gonorrhoeae.淋病奈瑟菌临床株和参考株对氯硫酰胺的敏感性。
Antimicrob Agents Chemother. 2017 Sep 22;61(10). doi: 10.1128/AAC.00929-17. Print 2017 Oct.
2
Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.淋病奈瑟菌抗菌药物敏感性监测 - 淋球菌分离株监测项目，美国 27 个监测点，2014 年。
MMWR Surveill Summ. 2016 Jul 15;65(7):1-19. doi: 10.15585/mmwr.ss6507a1.
3
Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.达累斯萨拉姆淋病奈瑟菌对抗菌药物的敏感性模式
East Afr Med J. 1999 Jun;76(6):330-4.
4
Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains.印度淋病奈瑟菌抗菌药物敏感性模式的变化趋势以及头孢曲松敏感性降低的淋病奈瑟菌菌株的出现。
J Antimicrob Chemother. 2007 Sep;60(3):582-6. doi: 10.1093/jac/dkm238. Epub 2007 Jun 29.
5
[Antimicrobal resistance of Neisseria gonorrhoeae strains in Hungary].[匈牙利淋病奈瑟菌菌株的抗菌耐药性]
Orv Hetil. 2015 Feb 8;156(6):226-9. doi: 10.1556/OH.2015.30079.
6
Fluoroquinolone-resistance in Neisseria gonorrhoeae, Hawaii, 1999, and decreased susceptibility to azithromycin in N. gonorrhoeae, Missouri, 1999.1999年夏威夷淋病奈瑟菌对氟喹诺酮类药物的耐药性，以及1999年密苏里州淋病奈瑟菌对阿奇霉素的敏感性降低。
MMWR Morb Mortal Wkly Rep. 2000 Sep 22;49(37):833-7.
7
Antimicrobial Susceptibility of Neisseria gonorrhoeae in Japan from 2000 to 2015.2000年至2015年日本淋病奈瑟菌的抗菌药物敏感性
Sex Transm Dis. 2017 Mar;44(3):149-153. doi: 10.1097/OLQ.0000000000000556.
8
The prevalence and antibiotics susceptibility pattern of Neisseria gonorrhoeae in patients attending OPD clinics at St. Mary's Hospital Lacor Uganda.乌干达拉科尔圣玛丽医院门诊患者中淋病奈瑟菌的流行情况及抗生素敏感性模式。
J Prev Med Hyg. 2012 Dec;53(4):186-9.
9
Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.回顾性分析拉丁美洲和加勒比地区淋病奈瑟菌分离株的抗菌药物敏感性趋势（2000-2009 年）显示，对环丙沙星、阿奇霉素的耐药性不断增加，对头孢曲松的敏感性降低。
Sex Transm Dis. 2012 Oct;39(10):813-21. doi: 10.1097/OLQ.0b013e3182631c9f.
10
Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae.脑膜炎奈瑟菌和淋病奈瑟菌的新兴耐药性。
Expert Rev Anti Infect Ther. 2011 Feb;9(2):237-44. doi: 10.1586/eri.10.171.

引用本文的文献

1
A Specialized Polythioamide-Binding Protein Confers Antibiotic Self-Resistance in Anaerobic Bacteria.一种特殊的多硫酰胺结合蛋白赋予厌氧菌抗生素自我耐药性。
Angew Chem Int Ed Engl. 2022 Sep 12;61(37):e202206168. doi: 10.1002/anie.202206168. Epub 2022 Aug 3.
2
Epidemiology, Treatments, and Vaccine Development for Antimicrobial-Resistant Neisseria gonorrhoeae: Current Strategies and Future Directions.耐抗生素淋病奈瑟菌的流行病学、治疗方法和疫苗研发：当前策略和未来方向。
Drugs. 2021 Jul;81(10):1153-1169. doi: 10.1007/s40265-021-01530-0. Epub 2021 Jun 7.
3
An Unexpected Split-Merge Pathway in the Assembly of the Symmetric Nonribosomal Peptide Antibiotic Closthioamide.

本文引用的文献

1
Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors.氯硫酰胺的作用机制：细菌DNA回旋酶抑制剂多硫酰胺类的首个成员。
J Antimicrob Chemother. 2015 Sep;70(9):2576-88. doi: 10.1093/jac/dkv161. Epub 2015 Jul 14.
2
Is gonorrhea becoming untreatable?淋病会变得无法治疗吗？
Future Microbiol. 2014;9(2):189-201. doi: 10.2217/fmb.13.155.
3
Antiterminator-mediated unveiling of cryptic polythioamides in an anaerobic bacterium.抗终止子介导的厌氧细菌中隐秘聚硫酰胺的揭示
对称型非核糖体肽类抗生素克洛硫菌素的组装中一条意想不到的分合途径。
Angew Chem Int Ed Engl. 2021 Feb 19;60(8):4104-4109. doi: 10.1002/anie.202011741. Epub 2020 Dec 23.
4
Reconstitution of polythioamide antibiotic backbone formation reveals unusual thiotemplated assembly strategy.重建聚硫酰胺抗生素骨架形成揭示了不寻常的硫模板组装策略。
Proc Natl Acad Sci U S A. 2020 Apr 21;117(16):8850-8858. doi: 10.1073/pnas.1918759117. Epub 2020 Apr 7.
5
Reconstitution of Iterative Thioamidation in Closthioamide Biosynthesis Reveals Tailoring Strategy for Nonribosomal Peptide Backbones.迭代硫酰胺化在 Closthioamide 生物合成中的重建揭示了非核糖体肽骨架的修饰策略。
Angew Chem Int Ed Engl. 2019 Sep 9;58(37):13014-13018. doi: 10.1002/anie.201905992. Epub 2019 Aug 7.
6
Biosynthesis and Chemical Applications of Thioamides.硫代酰胺的生物合成与化学应用。
ACS Chem Biol. 2019 Feb 15;14(2):142-163. doi: 10.1021/acschembio.8b01022. Epub 2019 Jan 30.
7
Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.针对疫苗和其他卫生技术在应对 AMR 方面的价值进行经济评估。
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):12911-12919. doi: 10.1073/pnas.1717161115.
8
Natural products from anaerobes.厌氧菌来源的天然产物。
J Ind Microbiol Biotechnol. 2019 Mar;46(3-4):375-383. doi: 10.1007/s10295-018-2086-5. Epub 2018 Oct 3.
Angew Chem Int Ed Engl. 2012 Mar 5;51(10):2425-8. doi: 10.1002/anie.201108214. Epub 2012 Jan 27.
4
UK national guideline for the management of gonorrhoea in adults, 2011.《2011年英国成人淋病管理国家指南》
Int J STD AIDS. 2011 Oct;22(10):541-7. doi: 10.1258/ijsa.2011.011267.
5
Closthioamide: an unprecedented polythioamide antibiotic from the strictly anaerobic bacterium Clostridium cellulolyticum.氯硫酰胺：一种来自严格厌氧细菌解纤维素梭菌的前所未有的聚硫酰胺类抗生素。
Angew Chem Int Ed Engl. 2010 Mar 8;49(11):2011-3. doi: 10.1002/anie.200906114.
6
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.多重耐药淋病奈瑟菌出现后，世界卫生组织西太平洋区域目前关于第三代头孢菌素使用建议的影响。
Sex Transm Infect. 2009 Aug;85(4):256-8. doi: 10.1136/sti.2008.035337. Epub 2009 Mar 3.